These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8549075)

  • 1. Differential effects of a novel non-peptide endothelin receptor antagonist (bosentan) in rat liver and vasculature.
    Phillips PA; Risvanis J; Aldred K; Burrell LM; Bartholomeusz B
    Clin Sci (Lond); 1995 Dec; 89(6):575-9. PubMed ID: 8549075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor- and non-receptor-mediated clearance of big-endothelin and endothelin-1: differential effects of acute and chronic ETA receptor blockade.
    Burkhardt M; Barton M; Shaw SG
    J Hypertens; 2000 Mar; 18(3):273-9. PubMed ID: 10726713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ETA and ETB receptors mediate contraction to endothelin-1 in renal artery of aging SHR. Effects of FR139317 and bosentan.
    Seo B; Lüscher TF
    Hypertension; 1995 Apr; 25(4 Pt 1):501-6. PubMed ID: 7721390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist.
    Clozel M; Breu V; Gray GA; Kalina B; Löffler BM; Burri K; Cassal JM; Hirth G; Müller M; Neidhart W
    J Pharmacol Exp Ther; 1994 Jul; 270(1):228-35. PubMed ID: 8035319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelin B receptor-mediated vasoconstriction induced by endothelin A receptor antagonist.
    Zhang Y; Oliver JR; Horowitz JD
    Cardiovasc Res; 1998 Sep; 39(3):665-73. PubMed ID: 9861310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paracrine renal endothelin system in rats with liver cirrhosis.
    Hocher B; Zart R; Diekmann F; Rohmeiss P; Distler A; Neumayer HH; Bauer C; Gross P
    Br J Pharmacol; 1996 May; 118(2):220-7. PubMed ID: 8735618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a region of the human endothelin ETA receptor required for interaction with bosentan.
    Adachi M; Furuichi Y; Miyamoto C
    Eur J Pharmacol; 1994 Oct; 269(2):225-34. PubMed ID: 7851498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelin-1 is involved in norepinephrine-induced ventricular hypertrophy in vivo. Acute effects of bosentan, an orally active, mixed endothelin ETA and ETB receptor antagonist.
    Kaddoura S; Firth JD; Boheler KR; Sugden PH; Poole-Wilson PA
    Circulation; 1996 Jun; 93(11):2068-79. PubMed ID: 8640984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels.
    Seo B; Oemar BS; Siebenmann R; von Segesser L; Lüscher TF
    Circulation; 1994 Mar; 89(3):1203-8. PubMed ID: 8124808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihypertensive effect of an endothelin receptor antagonist in DOCA-salt spontaneously hypertensive rats.
    Schiffrin EL; Sventek P; Li JS; Turgeon A; Reudelhuber T
    Br J Pharmacol; 1995 Aug; 115(8):1377-81. PubMed ID: 8564194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of bosentan (Ro 47-0203), an ETA-, ETB-receptor antagonist, on regional haemodynamic responses to endothelins in conscious rats.
    Gardiner SM; Kemp PA; March JE; Bennett T
    Br J Pharmacol; 1994 Jul; 112(3):823-30. PubMed ID: 7921608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of endothelin in mediating neurogenic plasma extravasation in rat dura mater.
    Brändli P; Löffler BM; Breu V; Osterwalder R; Maire JP; Clozel M
    Pain; 1996 Feb; 64(2):315-322. PubMed ID: 8740609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Ro 47-0203 and PD155080 on the plasma kinetics, receptor binding and vascular effects of endothelin in the pig.
    Hemsén A; Modin A; Wanecek M; Malmström RE; Weitzberg E
    Eur J Pharmacol; 1996 Dec; 318(2-3):369-76. PubMed ID: 9016927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional variation in appearance of vascular contractile endothelin-B receptors following organ culture.
    Adner M; Uddman E; Cardell LO; Edvinsson L
    Cardiovasc Res; 1998 Jan; 37(1):254-62. PubMed ID: 9539881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelin in the pulmonary circulation with special reference to hypoxic pulmonary vasoconstriction.
    Holm P
    Scand Cardiovasc J Suppl; 1997; 46():1-40. PubMed ID: 9265559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of endothelin ETA receptors masks the constrictor role of endothelin ETB receptors in rat isolated small mesenteric arteries.
    Mickley EJ; Gray GA; Webb DJ
    Br J Pharmacol; 1997 Apr; 120(7):1376-82. PubMed ID: 9105715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelin receptor subtypes in small arteries. Studies with FR139317 and bosentan.
    Takase H; Moreau P; Lüscher TF
    Hypertension; 1995 Apr; 25(4 Pt 2):739-43. PubMed ID: 7721425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of three non-peptide endothelin receptor ligands using human cloned ETA and ETB receptors.
    Buchan KW; Alldus C; Christodoulou C; Clark KL; Dykes CW; Sumner MJ; Wallace DM; White DG; Watts IS
    Br J Pharmacol; 1994 Aug; 112(4):1251-7. PubMed ID: 7952888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelin-induced inositol phosphate formation in rat kidney. Studies on receptor subtypes, G-proteins and regulation during ontogenesis.
    Becker K; Erdbrügger W; Heinroth-Hoffmann I; Michel MC; Brodde OE
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Nov; 354(5):572-8. PubMed ID: 8938654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro characterization of Ro 46-2005, a novel synthetic non-peptide endothelin antagonist of ETA and ETB receptors.
    Breu V; Löffler BM; Clozel M
    FEBS Lett; 1993 Nov; 334(2):210-4. PubMed ID: 8224248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.